AngioDynamics Inc (ANGO) stock
ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 12/3011% below fair value
$11.32−0.17 (-1.48%)
Close on Nov 18, 2026Market cap $476.06MP/E –Yield –
AngioDynamics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
AngioDynamics's free cash flow for the twelve months ending Aug 31, 2026 was $1.44M. For fiscal 2026 it was $508.00K. Over ten years it grew -35.8% a year on average. The highest annual figure on record is $52.74M in fiscal 2017.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | $508.00K | – |
| FY2025 | May 31, 2025 | -$14.59M | – |
| FY2024 | May 31, 2024 | -$30.68M | – |
| FY2023 | May 31, 2023 | -$3.73M | – |
| FY2022 | May 31, 2022 | -$11.49M | -160.8% |
| FY2021 | May 31, 2021 | $18.91M | – |
| FY2020 | May 31, 2020 | -$21.79M | -163.5% |
| FY2019 | May 31, 2019 | $34.32M | -11.8% |
| FY2018 | May 31, 2018 | $38.90M | -26.3% |
| FY2017 | May 31, 2017 | $52.74M | +23.0% |
| FY2016 | May 31, 2016 | $42.89M | +199.9% |
| FY2015 | May 31, 2015 | $14.30M | +5.9% |
| FY2014 | May 31, 2014 | $13.51M | -7.0% |
| FY2013 | May 31, 2013 | $14.53M | +59.5% |
| FY2012 | May 31, 2012 | $9.11M | -70.5% |
| FY2011 | May 31, 2011 | $30.91M | -11.5% |
| FY2010 | May 31, 2010 | $34.92M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | -$15.71M | – |
| Q4 FY2026CQ2 2026 | May 31, 2026 | $17.04M | -5.5% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -$4.13M | – |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $4.24M | +152.9% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$16.65M | – |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $18.03M | +306.6% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$14.96M | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $1.68M | -64.4% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -$19.35M | – |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $4.44M | -70.2% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$13.13M | -1965.5% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $4.71M | -24.2% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -$26.69M | – |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $14.90M | +98.1% |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $704.00K | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $6.22M | +667.7% |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -$25.55M | – |
| Q4 FY2022CQ2 2022 | May 31, 2022 | $7.52M | -35.0% |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -$9.90M | -320.5% |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | $810.00K | -92.0% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -$9.93M | – |
| Q4 FY2021CQ2 2021 | May 31, 2021 | $11.58M | +382.3% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $4.49M | – |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $10.09M | +204.4% |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | -$7.25M | – |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $2.40M | -90.1% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | -$19.58M | -362.6% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | $3.31M | -72.9% |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | -$7.93M | – |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $24.20M | +5.1% |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $7.46M | +91.6% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | $12.23M | +29.4% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | -$9.56M | -476.9% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | $23.03M | +26.2% |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $3.89M | -72.1% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | $9.44M | -30.5% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | $2.54M | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | $18.25M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | $13.95M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $13.58M | – |
See a number that looks wrong?